Altered plasma visfatin levels and insulin resistance in patients with Alzheimer’s disease.
Autor: Sharifipour, Ehsan; Sharifimoghadam, Soroush; Hassanzadeh, Navid; Ghasemian Mojarad, Negin; Ghoreishi, Abdoreza; Hejazi, Seyyed Amir; Rohampour, Kambiz
Publication year: 2020
Acta neurologica Belgica
issn:2240-2993 0300-9009
doi: 10.1007/s13760-019-01084-9
Abstract:
Central insulin resistance is involved in the pathophysiology of Alzheimer’s disease (AD). Visfatin (VIS), an adipokine secreted from peripheral adipose tissue, is involved in energy balance and weight control. Besides its metabolic roles, VIS possesses insulin-mimetic, anti-apoptotic, and neuroprotective properties. In this study, we assessed the presence of a correlation between plasma VIS level and insulin resistance or AD. Sixty participants were enrolled in this study; 34 patients with AD and 26 healthy subjects. All subjects underwent comprehensive evaluations including Mini-mental score exam (MMSE) for the diagnosis of dementia. Subjects with MMSE score < 24 were added to the AD group, while healthy subjects should have a MMSE score > 27. Fasting blood sugar (FBS) and insulin levels were measured by enzyme-linked immunosorbent assay. The results indicate a significant elevation in FBS from 103 ± 3.0 to 147 ± 7.6 in AD patients (p ≤ 0.001). Additionally, 71% of AD patients developed insulin resistance, as the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) index increased from 2.9 ± 0.5 in healthy subjects to 5.2 ± 0.7 in AD patients (p ≤ 0.05). Body mass index and serum insulin level did not show a significant alteration, but serum VIS levels were significantly (p ≤ 0.01) lower in AD patients (11.15 ± 1.9 ng/ml) in comparison to control group (21.09 ± 2.3 ng/ml). There is a negative correlation between plasma VIS level and the HOMA-IR index (p < 0.05). The results of this study present clear evidence for systemic insulin resistance and decreased serum VIS level in non-obese, non-overweight patients with moderate to severe AD. Language: eng Rights: Pmid: 30707409 Tags: Humans; Aged; Female; Male; Adult; Middle Aged; Cytokines/*blood; Alzheimer disease; Dementia; Insulin Resistance/*physiology; Blood Glucose/metabolism; Insulin/blood; Adipose Tissue/metabolism; Nicotinamide Phosphoribosyltransferase/*blood; Alzheimer Disease/*blood/diagnosis; Insulin resistance; Plasma/*metabolism; Visfatin Link: https://pubmed.ncbi.nlm.nih.gov/30707409/
